Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SOLARA.NSthis companySolara Active Pharma Sciences Limited	₹648.05	-253.3×	1.5×	1.37×	13.46×	-3.2%	26.7%	6.4%	-0.5%	-0.6%	4.4%	0.5%	0.55×	3.41×	0.92×	0.96×	0.0%	4	2.71	2	C+
AARTIDRUGS.NSAarti Drugs Limited	₹499.75	14.97×	1.88×	1.14×	11.19×	-76.9%	29.2%	9.4%	7.6%	12.6%	10.1%	1.7%	0.37×	1.82×	7.19×	1.59×	0.6%	4	3.46	2	C
ALIVUS.NSAlivus Life Sciences Limited	₹1,474.40	21.18×	3.59×	4.69×	14.44×	-46.0%	44.6%	28.3%	22.1%	16.9%	15.6%	2.2%	0.02×	0.07×	134.39×	5.21×	0.5%	—	—	4	A-
ANUHPHR.NSAnuh Pharma Limited	₹82.78	16.37×	1.91×	0.87×	10.04×	12.6%	17.4%	6.5%	5.3%	11.7%	10.8%	-1.6%	0×	-0.12×	106.58×	2.22×	2.2%	—	—	2	C
GRANULES.NSGranules India Limited	₹799.20	25.35×	2.97×	2.81×	13.13×	-42.2%	43.0%	16.6%	11.1%	11.7%	10.1%	0.8%	0.3×	0.52×	7.77×	1.8×	0.2%	5	—	2	C+
IOLCP.NSIOL Chemicals and Pharmaceuticals Limited	₹202.95	15.52×	1.19×	0.92×	8.2×	-108.0%	21.7%	8.1%	5.9%	7.7%	6.9%	1.8%	0.08×	0.26×	12.97×	1.78×	1.4%	4	—	2	C
Peer median	—	16.37×	1.91×	1.14×	11.19×	-46.0%	29.2%	9.4%	7.6%	11.7%	10.1%	1.7%	0.08×	0.26×	12.97×	1.8×	0.6%	4	3.46	2	—